Profund Advisors’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $145K | Sell |
20,157
-14,738
| -42% | -$106K | 0.01% | 944 |
|
|
2025
Q1 | $209K | Buy |
34,895
+3,306
| +10% | +$19.8K | 0.01% | 889 |
|
|
2024
Q4 | $246K | Buy |
31,589
+8,167
| +35% | +$63.7K | 0.01% | 876 |
|
|
2024
Q3 | $253K | Sell |
23,422
-11,072
| -32% | -$120K | 0.01% | 905 |
|
|
2024
Q2 | $291K | Sell |
34,494
-73,992
| -68% | -$624K | 0.01% | 733 |
|
|
2024
Q1 | $729K | Buy |
108,486
+60,917
| +128% | +$409K | 0.03% | 447 |
|
|
2023
Q4 | $280K | Buy |
47,569
+14,366
| +43% | +$84.5K | 0.01% | 818 |
|
|
2023
Q3 | $324K | Sell |
33,203
-4,784
| -13% | -$46.6K | 0.02% | 628 |
|
|
2023
Q2 | $450K | Sell |
37,987
-7,275
| -16% | -$86.1K | 0.02% | 544 |
|
|
2023
Q1 | $488K | Buy |
+45,262
| New | +$488K | 0.03% | 510 |
|